Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(25%)

Results Posted

33%(1 trials)

Phase Distribution

Ph phase_2

25%

Ph not_applicable

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Detailed Status

Completed3

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (25.0%)

N/A3 (75.0%)

Trials by Status

recruiting125%

completed375%

Recent Activity

1 active trials

Showing 4 of 4

completedphase_2

Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis

NCT05160532

completednot_applicable

Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis

NCT07620678

recruitingnot_applicable

The Effectiveness of Dextrose Prolotherapy in Patients With Coccydynia

NCT07552298

completednot_applicable

Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis

NCT07479693

Clinical Trials (4)

Showing 4 of 4 trials

NCT05160532Phase 2

Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis

Completed

NCT07620678Not Applicable

Comparison of ESWT and Single-Session 5% Dextrose Prolotherapy in Lateral Epicondylitis

Completed

NCT07552298Not Applicable

The Effectiveness of Dextrose Prolotherapy in Patients With Coccydynia

Recruiting

NCT07479693Not Applicable

Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4